Reported 1 day ago
Dr Martens has projected a return to profit growth this financial year, fueled by CEO Ije Nwokorie's strategy to diversify into shoes, sandals, and bags, alongside their iconic boots. Following positive financial results that exceeded market expectations, the company's shares soared by 17%. Despite tariffs and a shift in consumer preference from boots, Dr Martens plans to focus on broader product offerings and minimize discounting in key markets, as they expand production in Vietnam and Laos.
Source: YAHOO